Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Estramustine (CAS 2998-57-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Estramustinum
Application:
Estramustine is an estrogen derivative
CAS Number:
2998-57-4
Molecular Weight:
440.4
Molecular Formula:
C23H31Cl2NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Estramustine, also known as estracyt or leo 275, is a synthetic molecule that acts as a microtubule assembly inhibitor. It inhibits endothelial cell proliferation (IC50 = 4.5 μM) and down-regulates prostate-specific antigen expression (IC50 = 10.97 μM). As an alkylating and antitumor agent, it demonstrates activity both in vitro and in vivo.This compound is a carbamate ester formed by combining estradiol and nornitrogen mustard. It binds to microtubule-associated proteins (MAPs) and tubulin, thereby hindering microtubule dynamics and inducing dose-dependent anaphase arrest. Additionally, estramustine possesses anti-androgenic effects. It is classified as an estrane steroid, belonging to the group of organic compounds with a structure based on the estrane skeleton, making it a steroid lipid molecule.This compound is involved in several enzymatic reactions and can be biosynthesized from 17beta-estradiol. It can also be converted into estramustine phosphate. With its role as an antineoplastic agent, alkylating agent, and radiation protective agent, estramustine acts as a carbamate ester, a 17beta-hydroxy steroid, and an organochlorine compound.


Estramustine (CAS 2998-57-4) References

  1. Estramustine potentiates taxane in prostate and refractory breast cancers.  |  Hamilton, A. and Muggia, F. 2001. Oncology (Williston Park). 15: 40-3. PMID: 11396364
  2. Radiation sensitizing effect of estramustine is not dependent on apoptosis.  |  Ståhlberg, K., et al. 2005. Anticancer Res. 25: 2873-8. PMID: 16080540
  3. Charge dependency of the effects of estramustine derivatives on microtubule assembly in vitro.  |  Wallin, M., et al. 1991. Acta Histochem Suppl. 41: 45-53. PMID: 1811268
  4. The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent.  |  Fridén, B., et al. 1991. Biochem Pharmacol. 42: 997-1006. PMID: 1908244
  5. Estramustine--a nitrogen mustard/steroid with antimicrotubule activity.  |  Tew, KD. and Stearns, ME. 1989. Pharmacol Ther. 43: 299-319. PMID: 2682681
  6. Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis.  |  Qin, Z., et al. 2016. Medicine (Baltimore). 95: e4801. PMID: 27684806
  7. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.  |  Stearns, ME., et al. 1988. J Cell Biol. 107: 2647-56. PMID: 3060470
  8. Estramustine binds MAP-2 to inhibit microtubule assembly in vitro.  |  Stearns, ME. and Tew, KD. 1988. J Cell Sci. 89 (Pt 3): 331-42. PMID: 3198696
  9. Estramustine-binding protein in rat and human prostate.  |  Forsgren, B. 1988. Scand J Urol Nephrol Suppl. 107: 56-8. PMID: 3287598
  10. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.  |  Hartley-Asp, B. 1984. Prostate. 5: 93-100. PMID: 6694918
  11. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins.  |  Smith, CD., et al. 1995. Cancer. 75: 2597-604. PMID: 7736407
  12. Estramustine: a novel radiation enhancer in human carcinoma cells.  |  Ryu, S., et al. 1994. Int J Radiat Oncol Biol Phys. 30: 99-104. PMID: 7916009
  13. Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmatic reticulum, and inhibits cell migration.  |  Rutberg, M. and Wallin, M. 1993. Acta Histochem. 95: 155-67. PMID: 8135088

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Estramustine, 100 mg

sc-353281
100 mg
$265.00

Estramustine, 1 g

sc-353281A
1 g
$743.00